AcelRx effects 1:20 reverse stock split; redeems Series A Preferred for $315K

TALPHERA, INC.

1:20 reverse stock split effective Oct 25, 2022; trading on split-adjusted basis on Nasdaq from Oct 26.
New CUSIP is 00444T 209; no fractional shares issued; cash paid in lieu.
Company redeemed all Series A Convertible Preferred Stock on Oct 12 for $315K aggregate.
Certificate of Elimination filed Oct 25 retiring the 3,000-share Series A designation.
Reverse split and preferred retirement approved by board and stockholders.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.